Sukumar Nagendran

Director & President and Head of R&D

Director & President and Head of R&D at Taysha Gene Therapies, Inc., filing insider transactions on 2026-07-10.

Total Purchases

—

0 transactions

Total Sales

$1.2M

1 transaction

Companies Traded

1 total filings

Active Since

2026-07-10

Last: 2026-07-10

Companies

Taysha Gene Therapies, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-10	TSHA	Sale	200.0K	$6.24	$1.2M	936.4K	SEC ↗